#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Stress cardiomyopathy Anti-glomerular basement membrane disease Neonatal asphyxia Extraskeletal ossification Granulomatosis with polyangiitis Cholangiosarcoma B-cell type acute leukaemia Optic glioma Short stature homeobox gene mutation Ependymoma Epidermolysis bullosa Transient ischaemic attack VEXAS syndrome Interstitial lung disease More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Life with Disease Marginal zone lymphoma refractory – Life with Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Carcinoid syndrome – Treatment Glomerulonephritis rapidly progressive Immunodeficiency congenital – Trials in Disease Cystic fibrosis – Trials in Disease Alagille syndrome – Treatment Bronchopulmonary dysplasia – Diagnostics Mantle cell lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glenzocimab NERANDOMILAST Risdiplam Chlorhexidine Gluconate Doxorubicin Hydrochloride Difelikefalin Mk-1084 Sodium 2-Hydroxylinoleate Imifoplatin Anselamimab Thymalfasin Ivosidenib Bms-986449-03 Levocabastine Hydrochloride MOLNUPIRAVIR Benfotiamine Iberdomide Cefoxitin Sodium Somatropin Lenacapavir Sodium More therapies…

    Learn about Your Condition

    Follicular lymphoma stage III Psychogenic seizure Choreoathetosis Spinal cord injury Anal cancer metastatic Pyoderma Anaemia Transient ischaemic attack Oropharyngeal cancer recurrent Phaeochromocytoma Ataxia telangiectasia Radiation skin injury Erythema migrans Infantile apnoea Magnetic resonance imaging More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metachromatic leukodystrophy

  • Long‑Term Monitoring of Malignancy Risk in Early‑Onset Metachromatic Leukodystrophy Patients Treated with atidarsagene autotemcel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    France Germany Italy The Netherlands Sweden

  • Study of Intrathecal Cebsulfase Alfa for Children with Late Infantile Metachromatic Leukodystrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Cebsulfase Alfa
    Belgium France Germany Greece Italy Spain

  • Study on Gene Therapy with Atidarsagene Autotemcel for Patients with Metachromatic Leukodystrophy

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    Italy

  • Study on Long-Term Safety and Efficacy of Cebsulfase Alfa for Children with Late Metachromatic Leukodystrophy Receiving Intrathecal Enzyme Replacement

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cebsulfase Alfa
    Czechia Denmark France Germany Italy

  • Study on the Effects of Atidarsagene Autotemcel for Patients with Late Juvenile Metachromatic Leukodystrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    Italy

  • Study of Atidarsagene Autotemcel for Treating Early Onset Metachromatic Leukodystrophy (MLD) in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!